Polymerase I and transcriptional release factor (PTRF) known as Cavin1 in serum EVs contributed to the detection of gliomas were hopeful biomarkers and may be a treatment target point for GBM [112]. The gene discussed is CAVIN1; the disease is glioblastoma.